Thomas L. Harrison, Director at Dipexium Pharmaceuticals, Inc. (DPRX), bought 2,000 shares at $12.00 ($24K) on 2014-03-18, disclosed to the SEC on 2014-03-20.
Open-market purchase of $24k DPRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| FSAM | SELL | 2017-12-11 | $24K | — | Filing → |
| ZYNE | BUY | 2015-08-12 | $175K | — | Filing → |
| FSAM | BUY | 2014-11-04 | $102K | — | Filing → |